Elimova, E., Ku, G. Y., Lee, K., Rha, S. Y., Wienke, S., Yalamanchili, G., Garfin, P. M., Loro, E., Shpektor, D., Ajani, J. A. (2026). Molecular circulating tumor DNA (ctDNA) profiling from patients (pts) treated with zanidatamab + chemotherapy (CT) in first-line (1L) HER2-positive (HER2+) advanced or metastatic gastroesophageal adenocarcinoma (mGEA).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4050